Utah Medical Products Inc (UTMD)

$69.6

+1.31

(+1.92%)▲

Market is closed - opens 7 PM, 04 Jun 2024

Insights on Utah Medical Products Inc

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 12.86M → 11.34M (in $), with an average decrease of 4.1% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 4.28M → 3.95M (in $), with an average decrease of 7.7% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 29.4% return, outperforming this stock by 56.1%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 45.7% return, outperforming this stock by 62.9%

Performance

  • $68.85
    $69.95
    $69.60
    downward going graph

    1.07%

    Downside

    Day's Volatility :1.57%

    Upside

    0.5%

    downward going graph
  • $65.91
    $97.75
    $69.60
    downward going graph

    5.3%

    Downside

    52 Weeks Volatility :32.57%

    Upside

    28.8%

    downward going graph

Returns

PeriodUtah Medical Products IncSector (Health Care)Index (Russel 2000)
3 Months
-2.36%
-1.0%
0.0%
6 Months
-17.33%
9.6%
0.0%
1 Year
-25.37%
11.0%
0.0%
3 Years
-17.22%
18.5%
-22.6%

Highlights

Market Capitalization
241.0M
Book Value
$35.6
Dividend Share
1.19
Dividend Yield
1.76%
Earnings Per Share (EPS)
4.49
PE Ratio
15.21
PEG Ratio
0.0
Profit Margin
33.39%
Operating Margin TTM
40.86%
Return On Assets TTM
8.65%
Return On Equity TTM
13.33%
Revenue TTM
49.0M
Revenue Per Share TTM
13.52
Quarterly Revenue Growth YOY
-9.4%
Gross Profit TTM
32.2M
EBITDA
23.5M
Diluted Eps TTM
4.49
Quarterly Earnings Growth YOY
-0.06
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Company Financials

FY18Y/Y Change
Revenue
42.0M
↑ 1.41%
Net Income
18.6M
↑ 118.15%
Net Profit Margin
44.18%
↑ 23.64%
FY19Y/Y Change
Revenue
46.9M
↑ 11.68%
Net Income
14.7M
↓ 20.63%
Net Profit Margin
31.4%
↓ 12.78%
FY20Y/Y Change
Revenue
42.2M
↓ 10.08%
Net Income
10.8M
↓ 26.68%
Net Profit Margin
25.6%
↓ 5.8%
FY21Y/Y Change
Revenue
49.1M
↑ 16.3%
Net Income
14.8M
↑ 36.95%
Net Profit Margin
30.15%
↑ 4.55%
FY22Y/Y Change
Revenue
52.3M
↑ 6.58%
Net Income
16.5M
↑ 11.39%
Net Profit Margin
31.51%
↑ 1.36%
FY23Y/Y Change
Revenue
50.2M
↓ 3.93%
Net Income
16.6M
↑ 0.98%
Net Profit Margin
33.12%
↑ 1.61%
Q4 FY22Q/Q Change
Revenue
13.6M
↑ 4.79%
Net Income
4.6M
↑ 6.43%
Net Profit Margin
33.55%
↑ 0.51%
Q1 FY23Q/Q Change
Revenue
4.7M
↓ 65.55%
Net Income
4.2M
↓ 7.49%
Net Profit Margin
90.1%
↑ 56.55%
Q2 FY23Q/Q Change
Revenue
12.9M
↑ 175.09%
Net Income
4.2M
↓ 0.33%
Net Profit Margin
32.64%
↓ 57.46%
Q3 FY23Q/Q Change
Revenue
12.5M
↓ 2.81%
Net Income
3.9M
↓ 6.31%
Net Profit Margin
31.47%
↓ 1.17%
Q4 FY23Q/Q Change
Revenue
12.3M
↓ 1.38%
Net Income
4.3M
↑ 8.92%
Net Profit Margin
34.75%
↑ 3.28%
Q1 FY24Q/Q Change
Revenue
11.3M
↓ 8.05%
Net Income
4.0M
↓ 7.7%
Net Profit Margin
34.89%
↑ 0.14%
FY18Y/Y Change
Total Assets
99.8M
↑ 7.57%
Total Liabilities
10.8M
↓ 26.31%
FY19Y/Y Change
Total Assets
109.8M
↑ 10.04%
Total Liabilities
8.7M
↓ 19.31%
FY20Y/Y Change
Total Assets
111.7M
↑ 1.78%
Total Liabilities
8.9M
↑ 2.62%
FY21Y/Y Change
Total Assets
115.6M
↑ 3.41%
Total Liabilities
8.4M
↓ 5.6%
FY22Y/Y Change
Total Assets
123.9M
↑ 7.19%
Total Liabilities
9.6M
↑ 14.2%
FY23Y/Y Change
Total Assets
135.5M
↑ 9.35%
Total Liabilities
7.1M
↓ 25.72%
Q4 FY22Q/Q Change
Total Assets
123.9M
↑ 4.61%
Total Liabilities
9.6M
↓ 5.95%
Q1 FY23Q/Q Change
Total Assets
127.8M
↑ 3.15%
Total Liabilities
9.8M
↑ 1.38%
Q2 FY23Q/Q Change
Total Assets
130.5M
↑ 2.12%
Total Liabilities
8.7M
↓ 10.65%
Q3 FY23Q/Q Change
Total Assets
131.2M
↑ 0.59%
Total Liabilities
7.5M
↓ 13.45%
Q4 FY23Q/Q Change
Total Assets
135.5M
↑ 3.21%
Total Liabilities
7.1M
↓ 5.25%
Q1 FY24Q/Q Change
Total Assets
135.4M
↓ 0.01%
Total Liabilities
7.7M
↑ 7.75%
FY18Y/Y Change
Operating Cash Flow
16.8M
↓ 0.44%
Investing Cash Flow
534.0K
↓ 133.44%
Financing Cash Flow
-4.8M
↑ 80.06%
FY19Y/Y Change
Operating Cash Flow
17.1M
↑ 1.32%
Investing Cash Flow
-21.5M
↓ 4133.71%
Financing Cash Flow
-4.2M
↓ 11.51%
FY20Y/Y Change
Operating Cash Flow
20.1M
↑ 18.06%
Investing Cash Flow
-860.0K
↓ 96.01%
Financing Cash Flow
-10.7M
↑ 153.94%
FY21Y/Y Change
Operating Cash Flow
21.2M
↑ 5.29%
Investing Cash Flow
-552.0K
↓ 35.81%
Financing Cash Flow
-10.9M
↑ 1.59%
FY22Y/Y Change
Operating Cash Flow
21.1M
↓ 0.26%
Investing Cash Flow
-818.0K
↑ 48.19%
Financing Cash Flow
-5.5M
↓ 49.71%
Q4 FY22Q/Q Change
Operating Cash Flow
5.7M
↑ 1.63%
Investing Cash Flow
-38.0K
↓ 88.16%
Financing Cash Flow
-920.0K
↓ 10.85%
Q1 FY23Q/Q Change
Operating Cash Flow
6.9M
↑ 21.74%
Investing Cash Flow
-43.0K
↑ 13.16%
Financing Cash Flow
-1.0M
↑ 14.02%
Q2 FY23Q/Q Change
Operating Cash Flow
4.9M
↓ 28.95%
Investing Cash Flow
-320.0K
↑ 644.19%
Financing Cash Flow
-1.0M
↓ 3.72%

Technicals Summary

Sell

Neutral

Buy

Utah Medical Products Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Utah Medical Products Inc
Utah Medical Products Inc
0.3%
-17.33%
-25.37%
-17.22%
-13.99%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
5.43%
29.51%
27.2%
45.72%
155.38%
Resmed Inc.
Resmed Inc.
-4.4%
28.39%
-6.63%
1.01%
81.81%
Becton, Dickinson And Company
Becton, Dickinson And Company
0.96%
0.53%
-5.96%
-0.76%
1.54%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-10.32%
-6.31%
-4.27%
-1.41%
182.66%
Alcon Ag
Alcon Ag
11.48%
22.41%
13.04%
27.67%
52.06%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Utah Medical Products Inc
Utah Medical Products Inc
15.21
15.21
0.0
0.0
0.13
0.09
0.02
35.6
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
72.45
72.45
7.13
6.29
0.16
0.08
NA
39.37
Resmed Inc.
Resmed Inc.
32.26
32.26
1.75
7.73
0.22
0.12
0.01
31.52
Becton, Dickinson And Company
Becton, Dickinson And Company
49.78
49.78
1.34
13.05
0.05
0.03
0.02
88.74
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
43.66
43.66
6.72
7.76
0.21
0.11
0.0
36.72
Alcon Ag
Alcon Ag
42.24
42.24
4.59
3.07
0.05
0.02
0.0
42.13
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Utah Medical Products Inc
Utah Medical Products Inc
NA
$241.0M
-13.99%
15.21
33.39%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$142.6B
155.38%
72.45
27.16%
Resmed Inc.
Resmed Inc.
Buy
$30.8B
81.81%
32.26
20.91%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$67.0B
1.54%
49.78
6.76%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$24.3B
182.66%
43.66
19.42%
Alcon Ag
Alcon Ag
Buy
$44.0B
52.06%
42.24
10.96%

Institutional Holdings

  • FMR Inc

    11.14%

  • BlackRock Inc

    6.08%

  • Renaissance Technologies Corp

    5.80%

  • Vanguard Group Inc

    5.19%

  • Dimensional Fund Advisors, Inc.

    4.58%

  • State Street Corporation

    2.29%

Company Information

utah medical products, inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in hundreds of countries around the world as the standard for obtaining optimal long term outcomes for their patients. for more information about utah medical products, inc., visit utmd’s website at www.utahmed.com.

Organization
Utah Medical Products Inc
Employees
169
CEO
Mr. Kevin L. Cornwell
Industry
Health Technology

Discover More

FAQs